Fred Alger Management’s Pliant Therapeutics PLRX Stock Holding History

Fred Alger Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-97,082	Closed	-$1.45M	–	465
2024 Q1	$1.45M	Sell	97,082 -24,705	-20%	-$408K	0.01%	358
2023 Q4	$2.21M	Buy	121,787 +5,782	+5%	+$87.9K	0.01%	321
2023 Q3	$2.01M	Buy	116,005 +7,862	+7%	+$136K	0.01%	318
2023 Q2	$1.96M	Sell	108,143 -968,492	-90%	-$22.9M	0.01%	338
2023 Q1	$28.6M	Buy	1,076,635 +1,056,584	+5,269%	+$30.1M	0.15%	141
2022 Q4	$388K	Sell	20,051 -6,268	-24%	-$131K	﹤0.01%	410
2022 Q3	$550K	Buy	+26,319	New	+$504K	﹤0.01%	394

Other funds holding PLRX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Fred Alger Management's PLRX Position: Q2 2024 in Review

Fred Alger Management sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 97,082 shares — an estimated $1.45M sold.

Fred Alger Management first reported a position in PLRX in Q3 2022 and held it in 7 quarters. The position peaked at $28.6M in Q1 2023. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

Fred Alger Management reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
Fred Alger Management sold 97,082 Pliant Therapeutics shares in Q2 2024, an estimated $1.45M.
Fred Alger Management first reported a position in Pliant Therapeutics in Q3 2022 and held it in 7 quarters.
Fred Alger Management's Pliant Therapeutics position peaked at $28.6M in Q1 2023.
143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.